Grace Therapeutics, Inc. (GRCE) Shareholders’ equity 2022–2023
Grace Therapeutics, Inc. (GRCE) shareholders’ equity at each fiscal year-end, per SEC filings.
$108.3MFY2023 · since FY2022: $55.7M → $108.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $108.3M | +94.5% |
| FY2022 | $55.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice